Modified Poliovirus Tested in Glioblastoma.
Results from a recent phase I clinical trial offer preliminary evidence that a modified poliovirus may improve overall survival in patients with glioblastoma. Some experts note, however, that the therapy needs to be studied in later-stage clinical trials.